Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL(TM) Study Data in Recessive Dystrophic Epidermolysis Bullosa

Stock Information for Coda Octopus Group Inc.

Loading

Please wait while we load your information from QuoteMedia.